Relay Therapeutics (RLAY) News Today $6.86 +0.10 (+1.48%) Closing price 04:00 PM EasternExtended Trading$7.12 +0.26 (+3.85%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RLAY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Relay Therapeutics, Inc. $RLAY Shares Sold by TD Asset Management IncOctober 24 at 4:02 AM | marketbeat.comPrivate Capital Advisors Inc. Grows Position in Relay Therapeutics, Inc. $RLAYOctober 22 at 7:06 AM | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Relay Therapeutics (RLAY)October 21 at 8:57 PM | theglobeandmail.comRelay Therapeutics (NASDAQ:RLAY) Hits New 52-Week High - Time to Buy?October 20, 2025 | marketbeat.comWeiss Ratings Reaffirms Sell (D-) Rating for Relay Therapeutics (NASDAQ:RLAY)October 16, 2025 | americanbankingnews.comRelay Therapeutics (NASDAQ:RLAY) Earns "Sell (D-)" Rating from Weiss RatingsOctober 14, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Shares Down 3.5% - Here's WhyOctober 13, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of "Moderate Buy" from AnalystsOctober 13, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Trading Up 7.5% - Should You Buy?October 10, 2025 | marketbeat.comRelay Therapeutics, Inc. $RLAY Shares Sold by Voya Investment Management LLCOctober 2, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Shares Up 7% - Time to Buy?September 26, 2025 | marketbeat.comRelay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608September 22, 2025 | finance.yahoo.comRelay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608September 21, 2025 | insidermonkey.comRelay Therapeutics (NASDAQ:RLAY) Shares Up 7.9% - Here's WhySeptember 19, 2025 | marketbeat.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Rating of "Buy" by BrokeragesSeptember 18, 2025 | marketbeat.comRelay Therapeutics, Inc. $RLAY Shares Sold by Goldman Sachs Group Inc.September 17, 2025 | marketbeat.comRelay Therapeutics, Inc. $RLAY Shares Purchased by Acadian Asset Management LLCSeptember 17, 2025 | marketbeat.comRelay Therapeutics, Inc. (RLAY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 10, 2025 | seekingalpha.comTrexquant Investment LP Lowers Holdings in Relay Therapeutics, Inc. $RLAYSeptember 9, 2025 | marketbeat.comRelay Therapeutics (RLAY) Receives a Buy from GuggenheimSeptember 9, 2025 | theglobeandmail.comParkman Healthcare Partners LLC Sells 312,496 Shares of Relay Therapeutics, Inc. $RLAYSeptember 8, 2025 | marketbeat.comInvesco Ltd. Has $484,000 Position in Relay Therapeutics, Inc. $RLAYSeptember 8, 2025 | marketbeat.comGuggenheim Gives Buy Rating to Relay Therapeutics (RLAY)September 8, 2025 | insidermonkey.comOMERS ADMINISTRATION Corp Makes New Investment in Relay Therapeutics, Inc. $RLAYSeptember 7, 2025 | marketbeat.comGuggenheim Initiates Coverage on Relay Therapeutics (NASDAQ:RLAY)September 6, 2025 | marketbeat.comWalleye Capital LLC Sells 825,589 Shares of Relay Therapeutics, Inc. $RLAYSeptember 6, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Trading Up 7.6% - What's Next?September 5, 2025 | marketbeat.comGuggenheim assumes Relay with Buy, names best ideaSeptember 4, 2025 | msn.comNuveen LLC Purchases Shares of 320,395 Relay Therapeutics, Inc. $RLAYSeptember 4, 2025 | marketbeat.comRelay Therapeutics assumed with a Buy at GuggenheimSeptember 3, 2025 | msn.comWill Relay Therapeutics (NASDAQ:RLAY) Spend Its Cash Wisely?August 30, 2025 | finance.yahoo.comHC Wainwright Issues Positive Outlook for RLAY EarningsAugust 30, 2025 | marketbeat.comCW Advisors LLC Makes New Investment in Relay Therapeutics, Inc. $RLAYAugust 30, 2025 | marketbeat.comVanguard Group Inc. Reduces Stock Position in Relay Therapeutics, Inc. $RLAYAugust 30, 2025 | marketbeat.comBrokers Offer Predictions for RLAY FY2026 EarningsAugust 29, 2025 | marketbeat.comRelay Therapeutics to Participate in Two Upcoming Investor Conferences in SeptemberAugust 28, 2025 | globenewswire.comRelay Therapeutics (NASDAQ:RLAY) Price Target Cut to $14.00 by Analysts at HC WainwrightAugust 28, 2025 | marketbeat.comRelay Therapeutics price target lowered to $14 from $16 at H.C. WainwrightAugust 27, 2025 | msn.comCandriam S.C.A. Sells 1,149,063 Shares of Relay Therapeutics, Inc. $RLAYAugust 26, 2025 | marketbeat.comLeerink Partners Reiterates a Buy Rating on Relay Therapeutics (RLAY) With a $12 PTAugust 26, 2025 | msn.comRelay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Recommendation of "Moderate Buy" by BrokeragesAugust 26, 2025 | marketbeat.comRaymond James Lowers Relay Therapeutics (RLAY) PT to $19 Following Q2 Results, Strategic Cost CutsAugust 18, 2025 | msn.comRelay Therapeutics (RLAY) Gets a Buy from Bank of America SecuritiesAugust 9, 2025 | theglobeandmail.comRelay Therapeutics (NASDAQ:RLAY) Shares Gap Down After Analyst DowngradeAugust 9, 2025 | marketbeat.comRelay Therapeutics (NASDAQ:RLAY) Price Target Lowered to $19.00 at Raymond James FinancialAugust 9, 2025 | marketbeat.comRelay (RLAY) Q2 Loss Narrows 41%August 7, 2025 | fool.comRelay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate UpdatesAugust 7, 2025 | globenewswire.comRelay Therapeutics Q2 2025 Earnings PreviewAugust 7, 2025 | seekingalpha.comPreview: Relay Therapeutics's EarningsAugust 7, 2025 | benzinga.comRelay Therapeutics (NASDAQ:RLAY) Shares Up 8.2% - Here's What HappenedAugust 5, 2025 | marketbeat.com Get Relay Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLAY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RLAY Media Mentions By Week RLAY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RLAY News Sentiment▼0.490.64▲Average Medical News Sentiment RLAY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RLAY Articles This Week▼45▲RLAY Articles Average Week Get the Latest News and Ratings for RLAY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Relay Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AKRO News KYMR News NAMS News PRAX News CRNX News LNTH News VKTX News MIRM News TLX News ACAD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RLAY) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump Issues Surprise Emergency OrderIs This Stock the 'Next Nvidia'? Billionaire Warren Buffett has been loading up on millions of shares of th...Altimetry | SponsoredTrade this between 9:30 and 10:45 am ESTIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
